Market Exploration: Non-Compressible Haemorrhage – Novel Technologies
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatment of NCH at a combat casualty scene.
Documents
Details
Summary
On behalf of the Research and Clinical Innovation, Surgeon General’s Department, DASA is running a Market Exploration to identify existing technologies from Technology Readiness Level (TRL) 3 and above.
This will allow a better understanding of the current market capability to inform future medical research, treatment and development.
Whilst potentially successful technologies and concepts may be exploited, please note that this request for information is not a commitment to subsequently launch a formal DASA competition.